NEDD4L and glioblastoma: By comparing expression levels of NEDD4L in GBM patients with normal controls using microarray and RNA sequencing (RNA Seq) data from TCGA database, we found that NEDD4L levels were significantly reduced in GBM patients compared to those in control groups (Fig 4A and 4B).